The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...

The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...

Artificial intelligence (AI) and other innovations in data science are making these advances possible – but at this point, ...

Sanofi has been given a reprimand by the UK's Prescription Medicines Code of Practice Authority (PMCPA), after admitting that ...

Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...

The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, tissue engineering, and pharmaceutical research. Some of the trends that ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining ...